Port Erin Biopharma shares up thanks to strong investment income
30th Dec 2014 09:10
Port Erin Biopharma Investments, a biotechnology and biopharmaceutical investor, doubled its income for the full year driven by strong growth in biotechnology in 2014. The company reported an increase in its investment income to £2.1m from £0.59m in the year before. Profit before tax also increased
Read moreAZ Electronic Materials directors try to minimize damage
10th Apr 2013 16:27
John Whybrow, the Chairman of AZ Electronic Materials, which on Tuesday tanked after it issued a warning on full year revenue, has shown his faith in the chemicals company by enlarging his shareholding. Whybrow acquired 40,000 shares at 254p each for a total trade value of £101,600, taking his sta
Read moreAvesco Chairman adds to stake, while fellow directors sell
30th Jan 2013 16:16
Avesco, an AIM-listed corporate services provider, said Wednesday that its Chairman, Richard Murray, acquired 200,000 ordinary shares at 150p a go, as a number of his fellow board members opted to downsize their holdings in the group. Murray's transaction was by far the largest, costing him a tota
Read more